Rice Hall James & Associates’s Protolabs PRLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.88M Sell
108,964
-4,625
-4% -$325K 0.43% 66
2026
Q1
$6.48M Sell
113,589
-974
-0.9% -$56.5K 0.36% 70
2025
Q4
$5.8M Sell
114,563
-7,419
-6% -$379K 0.32% 77
2025
Q3
$6.1M Sell
121,982
-23,485
-16% -$1.08M 0.33% 74
2025
Q2
$5.82M Sell
145,467
-6,351
-4% -$237K 0.31% 75
2025
Q1
$5.32M Sell
151,818
-965
-0.6% -$38K 0.31% 71
2024
Q4
$5.97M Buy
+152,783
New +$5.49M 0.33% 70
2016
Q4
Sell
-270,386
Closed -$16.2M 307
2016
Q3
$16.2M Sell
270,386
-1,420
-0.5% -$81.7K 0.85% 52
2016
Q2
$15.6M Buy
271,806
+118,787
+78% +$7.93M 0.9% 47
2016
Q1
$11.8M Buy
+153,019
New +$9.88M 0.68% 60

Other funds holding PRLB

Rice Hall James & Associates's PRLB Position: Q2 2026 in Review

Rice Hall James & Associates reduced its Protolabs (PRLB) stake by 4.1% in Q2 2026, selling an estimated $325K and leaving 108,964 shares worth $8.88M. The position accounts for 0.43% of the portfolio, ranked #66.

Rice Hall James & Associates first reported a position in PRLB in Q1 2016 and has held it in 10 quarters since. The position peaked at $16.2M in Q3 2016. 278 funds tracked by Wall St. Rank hold PRLB as of Q2 2026.

  • Rice Hall James & Associates held 108,964 shares of Protolabs worth $8.88M as of Q2 2026.
  • Rice Hall James & Associates sold 4,625 Protolabs shares in Q2 2026, an estimated $325K.
  • Protolabs made up 0.43% of Rice Hall James & Associates's portfolio in Q2 2026, its #66 holding.
  • Rice Hall James & Associates first reported a position in Protolabs in Q1 2016 and has held it in 10 quarters since.
  • Rice Hall James & Associates's Protolabs position peaked at $16.2M in Q3 2016.
  • 278 funds tracked by Wall St. Rank held Protolabs as of Q2 2026.

Based on Rice Hall James & Associates's 13F filing for Q2 2026, filed 7 Aug 2026.